rosacea
Information
- Disease name
- rosacea
- Disease ID
- DOID:8881
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06033352 | Active, not recruiting | Phase 2 | Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea | September 12, 2023 | September 30, 2024 |
| NCT04275999 | Active, not recruiting | Phase 2 | Rosacea and Ivermectin | April 16, 2021 | December 2024 |
| NCT00279890 | Completed | Phase 1 | Topical Agent for Treatment of Red Skin | July 2005 | January 2007 |
| NCT00348335 | Completed | Phase 4 | Efficacy of Topical Cyclosporin for Ocular Rosacea | June 2006 | September 2007 |
| NCT00436527 | Completed | Phase 4 | Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application | August 2006 | August 2006 |
| NCT00495313 | Completed | Phase 4 | Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens | March 2007 | December 2007 |
| NCT00621218 | Completed | Phase 2 | A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea | February 2008 | December 2008 |
| NCT00667173 | Completed | Phase 2 | A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea | November 2007 | July 2008 |
| NCT00668655 | Completed | An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1% | February 2008 | March 2008 | |
| NCT00681603 | Completed | N/A | Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization | August 2007 | February 2008 |
| NCT00710489 | Completed | Potential Research Study Participant Registry | May 2008 | September 5, 2018 | |
| NCT00823901 | Completed | Phase 2/Phase 3 | Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea | February 2009 | October 2010 |
| NCT00892281 | Completed | Phase 4 | ORCA - Oracea® for Rosacea: A Community-based Assessment | April 2009 | October 2009 |
| NCT00940992 | Completed | Phase 2 | A Study of DER 45-EV Gel to Treat Rosacea | January 2012 | January 2013 |
| NCT00991198 | Completed | Phase 2 | The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage | September 2009 | January 2010 |
| NCT00126399 | Completed | Phase 3 | A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea | June 2004 | April 2005 |
| NCT00249782 | Completed | Phase 2 | A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea. | November 2005 | May 2006 |
| NCT03094403 | Completed | Phase 1 | To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel | July 1, 2016 | April 1, 2017 |
| NCT03193372 | Completed | A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea | July 20, 2017 | November 15, 2017 | |
| NCT03253666 | Completed | Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) | January 2017 | May 2018 | |
| NCT03263273 | Completed | Phase 2 | Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea | October 30, 2017 | July 1, 2019 |
| NCT03287791 | Completed | Phase 3 | A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea | July 19, 2016 | June 22, 2017 |
| NCT03340961 | Completed | Phase 2 | A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules | October 1, 2017 | March 31, 2019 |
| NCT03352323 | Completed | Phase 3 | An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea | October 18, 2017 | March 30, 2018 |
| NCT03380390 | Completed | Phase 4 | Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea | December 4, 2017 | June 15, 2018 |
| NCT03392558 | Completed | N/A | The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea | January 1, 2018 | May 1, 2018 |
| NCT03424304 | Completed | N/A | Evaluation of Cutera Excel V™ Laser With Green Genesis and Micro-Lens Array (MLA)Attachment | November 6, 2017 | June 30, 2018 |
| NCT03472859 | Completed | N/A | Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser | October 1, 2017 | June 9, 2018 |
| NCT03478436 | Completed | Phase 1 | Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers | July 2016 | October 25, 2016 |
| NCT03590366 | Completed | Phase 2 | A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea | July 2, 2018 | March 5, 2019 |
| NCT03655197 | Completed | Early Phase 1 | Lipidome and Microbiome Profile of the Eye in Rosacea | November 2, 2017 | July 1, 2021 |
| NCT03689010 | Completed | Phase 1 | To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea | December 12, 2017 | September 28, 2018 |
| NCT03841032 | Completed | N/A | 4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness | January 28, 2019 | February 25, 2019 |
| NCT03872050 | Completed | Deep Phenotyping of Rosacea and Migraine | September 14, 2018 | October 29, 2019 | |
| NCT03878784 | Completed | N/A | PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea | November 12, 2018 | December 19, 2019 |
| NCT03954444 | Completed | Phase 3 | A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream" | April 15, 2019 | February 27, 2020 |
| NCT04472546 | Completed | N/A | Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis | December 13, 2019 | February 2, 2024 |
| NCT04508205 | Completed | Phase 1 | CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes | October 26, 2018 | April 18, 2019 |
| NCT04508660 | Completed | Phase 1 | CGB-400 for the Reduction of Facial Redness | October 26, 2018 | April 18, 2019 |
| NCT04886739 | Completed | Phase 2 | CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea | May 7, 2021 | December 22, 2021 |
| NCT05014906 | Completed | Phase 4 | Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea | May 2010 | September 2011 |
| NCT05094700 | Completed | N/A | A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants | October 25, 2021 | November 30, 2021 |
| NCT05278624 | Completed | Phase 2 | Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea | April 15, 2022 | February 17, 2023 |
| NCT05562661 | Completed | M89PF in Rosacea Associated With Erythema and Sensitive Skin | January 2, 2021 | February 28, 2021 | |
| NCT05597462 | Completed | Phase 1 | Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks | September 30, 2022 | May 30, 2023 |
| NCT06271135 | Completed | N/A | Assessing the Quality of Life of Patients With Rosacea | May 8, 2017 | November 30, 2018 |
| NCT01174030 | Completed | Phase 2 | Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea | August 2010 | January 2011 |
| NCT01308619 | Completed | Phase 4 | Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo | April 2011 | August 2012 |
| NCT01318733 | Completed | Phase 3 | Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea | March 2011 | July 2012 |
| NCT01355458 | Completed | Phase 3 | Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea | May 2011 | December 2011 |
| NCT01355471 | Completed | Phase 3 | Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea | May 2011 | January 2012 |
| NCT01398280 | Completed | Early Phase 1 | Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation | July 2011 | December 2012 |
| NCT01426269 | Completed | Phase 4 | Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo | September 2011 | June 2013 |
| NCT01451619 | Completed | Phase 1 | A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155) | November 2011 | April 2012 |
| NCT01513863 | Completed | Phase 1 | A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea | August 2011 | September 2012 |
| NCT01529996 | Completed | N/A | Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness | January 2012 | August 2012 |
| NCT01579084 | Completed | Phase 1 | Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea | April 2012 | June 2012 |
| NCT01614743 | Completed | Phase 2 | A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea | June 2012 | November 2013 |
| NCT01618864 | Completed | N/A | Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea | March 2012 | December 2012 |
| NCT01631656 | Completed | N/A | Combination Gel and Vascular ND in Mild to Moderate Rosacea | July 2010 | February 2011 |
| NCT01636765 | Completed | Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale | May 2012 | July 2012 | |
| NCT01659853 | Completed | Phase 3 | Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea | September 2012 | December 2012 |
| NCT01735201 | Completed | Phase 2 | AGN-199201 for the Treatment of Erythema With Rosacea | December 2012 | June 2013 |
| NCT01740934 | Completed | N/A | A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea | November 2012 | August 2013 |
| NCT01789775 | Completed | Phase 3 | Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea | December 2012 | October 2013 |
| NCT01885000 | Completed | Phase 3 | Patient-Reported Outcome Of Facial Erythema (PROOF) | July 1, 2013 | November 14, 2013 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT01993446 | Completed | Phase 2 | A Safety and Efficacy Study of DRM02 in Subjects With Rosacea | October 2013 | March 2014 |
| NCT02075671 | Completed | Phase 4 | Photodynamic Therapy for Papulopustular Rosacea | April 24, 2014 | August 15, 2019 |
| NCT02095158 | Completed | Phase 3 | A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea | April 2014 | September 2015 |
| NCT02120924 | Completed | Phase 3 | A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea | July 2013 | September 2014 |
| NCT02131636 | Completed | Phase 3 | Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea | May 2014 | December 2014 |
| NCT02132117 | Completed | Phase 3 | Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea | June 2014 | May 2015 |
| NCT02144181 | Completed | N/A | Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea | May 2014 | October 2016 |
| NCT02204254 | Completed | N/A | RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea | March 2014 | June 7, 2021 |
| NCT02249065 | Completed | Phase 4 | Mirvaso in Use Study | September 2014 | August 2015 |
| NCT02289352 | Completed | Phase 3 | Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea | July 2014 | December 2014 |
| NCT02292797 | Completed | Assessment of the Rosacea Prevalence in the General Population | September 2013 | February 2014 | |
| NCT02292836 | Completed | Rosacea Prevalence in General Population - Pilot Study | August 2012 | February 2013 | |
| NCT02300129 | Completed | Phase 2 | Effect of CD07805/47 Gel in Rosacea Flushing | April 2014 | June 2014 |
| NCT02385240 | Completed | Phase 3 | Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea | March 2015 | December 2015 |
| NCT02547441 | Completed | Phase 3 | Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle | December 2015 | April 13, 2018 |
| NCT02576847 | Completed | Phase 3 | Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel | October 2015 | February 8, 2018 |
| NCT02576860 | Completed | Phase 3 | Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle | October 2015 | September 5, 2017 |
| NCT02583009 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea | October 2014 | |
| NCT02601963 | Completed | Phase 2 | Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea | September 2015 | August 2016 |
| NCT02602470 | Completed | Preferences & Treatment Satisfaction Drivers in Rosacea Patients | January 8, 2015 | March 10, 2016 | |
| NCT02616250 | Completed | Phase 4 | MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. | December 2015 | September 2016 |
| NCT02637232 | Completed | Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE) | October 2015 | May 2016 | |
| NCT02749786 | Completed | N/A | Genetic Basis of Rosacea Study (Control) | January 21, 2016 | August 1, 2016 |
| NCT02774590 | Completed | Phase 1 | Timolol for the Treatment of Acne and Rosacea | March 2016 | March 2021 |
| NCT02787616 | Completed | Genetic Basis of Rosacea | April 13, 2012 | November 16, 2018 | |
| NCT02795117 | Completed | Phase 3 | Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea | May 2016 | February 2017 |
| NCT02800148 | Completed | Phase 3 | Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face | November 2016 | October 2017 |
| NCT02806414 | Completed | Phase 1/Phase 2 | Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation. | July 2016 | May 2021 |
| NCT02828241 | Completed | Phase 2 | A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 | July 2016 | November 2017 |
| NCT03035955 | Completed | Phase 2/Phase 3 | Azelaic Acid on Demodex Counts in Rosacea | December 2010 | February 2, 2012 |
| NCT03048058 | Completed | Phase 4 | Internet Surveys and Their Impact on Adherence for Rosacea | May 5, 2016 | June 2017 |
| NCT03075891 | Completed | Phase 4 | Oracea Soolantra Association in Participants With Severe Rosacea | July 5, 2017 | February 8, 2018 |
| NCT06307288 | Enrolling by invitation | Phase 4 | Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea | October 16, 2023 | June 1, 2024 |
| NCT05747391 | Not yet recruiting | Assessment of Rosacea Patients' Clinical Trial Experiences | March 2024 | March 2026 | |
| NCT05861310 | Not yet recruiting | Phase 1 | Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy | May 2023 | December 2023 |
| NCT06072066 | Not yet recruiting | N/A | Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea | October 15, 2023 | April 28, 2024 |
| NCT05771298 | Recruiting | N/A | Potassium Titanyl Phosphate Laser Versus Pulsed Dye Laser for Rosacea - a Prospective Study | February 1, 2023 | June 1, 2023 |
| NCT05942248 | Recruiting | N/A | The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis | June 6, 2023 | April 6, 2024 |
| NCT06312813 | Recruiting | Phase 2 | Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea | February 27, 2024 | December 2028 |
| NCT04108897 | Recruiting | Early Phase 1 | Analysis of the Microbiome in Rosacea | September 17, 2019 | September 2026 |
| NCT06282679 | Recruiting | N/A | Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea | April 1, 2022 | June 28, 2024 |
| NCT03989492 | Recruiting | N/A | Role of the Sympathetic Nervous System in Rosacea | May 24, 2019 | August 2024 |
| NCT05815511 | Recruiting | N/A | Clinical Trial to Evaluate the Effect of a Probiotic Mixture on the Rosacea Evolution | April 4, 2022 | July 4, 2024 |
| NCT03756389 | Suspended | Phase 2 | Evaluation of Topical Application of BMX-010 in Subjects With Rosacea | January 3, 2018 | March 2025 |
| NCT04336163 | Terminated | N/A | Skin Imaging to Inform Laser Treatments | September 20, 2019 | July 8, 2022 |
| NCT01125930 | Terminated | Phase 3 | Atralin Gel for the Treatment of Rosacea | May 2010 | January 2013 |
| NCT01134991 | Terminated | Phase 2 | Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients | June 2010 | |
| NCT00395226 | Terminated | N/A | Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial | July 2006 | July 2008 |
| NCT05401422 | Unknown status | N/A | Brimonidine in Rosacea | May 25, 2022 | September 15, 2022 |
| NCT03211585 | Unknown status | N/A | EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA | October 2016 | December 2018 |
| NCT03228927 | Unknown status | Characterization of the Facial and Gut Microbiome in Rosacea | August 5, 2017 | August 6, 2017 | |
| NCT04377841 | Unknown status | Facial Demodicosis and Ocular Demodicosis | April 13, 2020 | December 14, 2020 | |
| NCT02556827 | Unknown status | Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients | July 2015 | December 2015 | |
| NCT04419259 | Unknown status | Phase 2 | Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea | June 9, 2020 | August 2021 |
| NCT04898582 | Unknown status | N/A | Clinical Benefit of M89PB in Subjects With Rosacea Associated With Erythema and Sensitive Skin | May 18, 2021 | May 18, 2021 |
| NCT01828177 | Unknown status | Phase 2 | An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea | June 2013 | June 2014 |
| NCT05045469 | Unknown status | Phase 2 | Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea | August 4, 2021 | August 4, 2023 |
| NCT02036229 | Unknown status | Phase 3 | Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis | February 2014 | June 2016 |
| NCT04889703 | Withdrawn | N/A | A Pilot Study Testing the Effects of Chemical Peels in Patients With Rosacea | December 2022 | May 2024 |
| NCT01359228 | Withdrawn | Phase 2 | Rifaximin Treatment of Papulopustular Rosacea | April 2013 | December 2014 |
| NCT03053700 | Withdrawn | Phase 4 | Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea | December 1, 2018 | January 2, 2019 |
- Disase is a (Disease Ontology)
- DOID:37
- Cross Reference ID (Disease Ontology)
- ICD10CM:L71
- Cross Reference ID (Disease Ontology)
- ICD9CM:695.3
- Cross Reference ID (Disease Ontology)
- MESH:D012393
- Cross Reference ID (Disease Ontology)
- NCI:C97136
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:1612004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0035854
- Exact Synonym (Disease Ontology)
- Acne roscea
- Exact Synonym (Disease Ontology)
- Acne, erythematosa
- ICD10 preferred id (Insert disease from ICD10)
- D0009903
- ICD10 class code (Insert disease from ICD10)
- L71
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012393